1887
2 - Qatar Health 2021 Conference abstracts
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Lung tomography is used to evaluate the lung parenchyma in diffuse interstitial lung disease. This type of injury can be caused by COVID-19 which emerged in Wuhan China, in December 2019.1 Typical Computed Tomography (CT) findings in individuals with COVID-19 are ground glass opacities, particularly in the peripheral and lower lobes, and bilateral multiple lobular and subsegmental areas of consolidation.2 The authors validated the use of baseline chest x-ray severity scores as an independent prognostic indicator of outcomes in COVID-19 patients.3 To describe tomographic, radiological, clinical, and laboratory findings associated with worse evolution in COVID-19 patients. This is a descriptive observational study based on 15 patients infected with COVID-19 in the Cuban Hospital, in Qatar, between March and June 2020, and for whom a CT scan of the chest was performed. The facility was mainly dedicated to treat COVID-19 patients. Poor outcome was defined as patient needing intubation, Intensive Care Unit (ICU) admission, or death. Variables such as age, gender, nationality, body mass index (BMI), smoking habit, presence of comorbidities, laboratory tests (leukogram (WBC), lactate dehydrogenase (LDH), c-reactive protein (CRP), and glycemia), and the severity of radiological and tomographic findings were collected. The quantitative variables were dichotomized according to their values. The outcome of our patients based on the variables collected is shown in Table 1. Diabetes mellitus and obesity were common comorbidities associated with poor patient outcome. The evolutive abnormal leukogram, glycemia, C-reactive protein were more abundant in patients with poor outcome. Regarding radiographic variables, 5 affected quadrants was the most observed radiological finding (Figure 1). In the chest tomography the most described was mild severity followed by severe score (Table 1). This sample is too small to make sound conclusions regarding our observations so a larger sample size study is required to confirm these results.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.qhc.9
2021-09-07
2021-09-27
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/2/jemtac.2021.qhc.9.html?itemId=/content/journals/10.5339/jemtac.2021.qhc.9&mimeType=html&fmt=ahah

References

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patient infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:(10223):497–506.
    [Google Scholar]
  2. Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology. 2020; 296:(2):E113–E114.
    [Google Scholar]
  3. Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, et al. Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19. Radiology. 2020; 297:(1):E197–E206.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.qhc.9
Loading
/content/journals/10.5339/jemtac.2021.qhc.9
Loading

Data & Media loading...

  • Article Type: Conference Abstract
Keyword(s): COVID-19 , pneumonia , respiratory infection , respiratory insufficiency and tomography
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error